Relationship between serum and saliva antibodies to Candida and isolation of Candida species from the mucosa of HIV-infected individuals

Mycoses

Volumn 52, Issue 3, 2009, Pages 246-250

  Castro, Gleusa ^a   Martinez, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; Candida; HIV 1 infection; Mucosal colonisation; Oral candidiasis; Salivary antibodies

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CANDIDA; CANDIDIASIS; CHEEK MUCOSA; CONTROLLED STUDY; FEMALE; FUNGUS ISOLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALIVA LEVEL; SPECIES IDENTIFICATION; THRUSH;

ADULT; ANTIBODIES, FUNGAL; CANDIDA; CANDIDIASIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MUCOUS MEMBRANE; SALIVA; YOUNG ADULT;

CANDIDA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 63849306344     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01594.x     Document Type: Article

References (23)

1. Ohmit SE, Sobel JD, Schuman P et al. Longitudinal study of mucosal Candida species colonisation and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk seronegative women. J Infect Dis 2003 1 : 118 27.
2. Sanchez-Vargas LO, Ortiz-Lopez NG, Villar M et al. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. Rev Iberoam Micol 2005 22 : 83 92.
3. Santana PL, Milan EP, Martinez R et al. Multicenter Brazilian study of oral Candida species isolated from AIDS patients. Mem Inst Oswaldo Cruz 2002 2 : 253 7.
4. Fidel PL. Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv Dent Res 2006 1 : 80 84.
5. Farah CS, Ashman RB. Active and passive immunization against oral Candida albicans infection in a murine model. Oral Microbiol Immunol 2005 20 : 376 81.
6. Han Y, Riesselman MH, Cutler JE. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun 2000 68 : 1649 54.
7. Irman N, Carpenter CC, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal Candida infection in HIV-seropositive women. Am J Med 1990 89 : 142 6.
8. Hung CC, Yang YL, Lauderdale TL et al. Colonisation of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol 2005 43 : 1600 3.
9. Repentigny L, Lewandowski D, Jolicoeur P. Imunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 2004 4 : 729 59.
10. Fernandez-Feijoo J, Diz-Dios P, Otero-Cepeda XL et al. Prective value of oral candidiais as a marker of progression to AIDS. Med Oral Patol Oral Cir Bucal 2005 1 : 36 40.
11. Cassone A, De Bernardis F, Torosantucci A et al. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 1999 180 : 448 53.
12. Drobacheff C, Millon L, Monod M et al. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clin Chem Lab Med 2001 39 : 519 26.
13. Wozniak KL, Leigh JE, Hager S, Swobada RK, Fidel PL Jr. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. J Infect Dis 2002 185 : 1269 76.
14. Muller F, Froland SS, Hvatum M, Radl J, Brandtzaeg P. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 1991 83 : 203 9.
15. Wray SD, Felix DH, Cumming CG. Alteration of humoral responses to Candida in HIV infection. Br Dent J 1990 168 : 326 9.
16. Belazi M, Fleva A, Drakoulakos D, Panayiotidou D. Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects. Int J STD AIDS 2002 13 : 373 7.
17. Kroidl A, Schaeben A, Oette M et al. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy. Eur J Med Res 2005 10 : 448 53.
18. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among. MMWR 1993 41 : 1 19.
19. Warren NG, Hazen KC. Candida, Cryptococcus and other yeasts of medical importance. In : Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds Manual of Clinical Microbiology, 6th edn. Washington : ASM Press, 1995 : 723 37.
20. Restrepo A, Jimenez BE. Growth of Paracoccidioides brasiliensis yeast phase in a chemically defined medium. J Clin Microbiol 1980 12 : 279 81.
21. Challacombe SJ, Sweet SP. Salivary and mucosal immune responses to HIV and co-pathogens. Oral Dis 1997 3 : 79 84.
22. Tylenda CA, Larsen J, Yeh CK, Lane HC, Fox PC. High levels of oral yeasts in early HIV-1 infection. J Oral Pathol Med 1989 18 : 520 4.
23. Coogan MM, Sweet SP, Challacombe SJ. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 1994 62 : 892 6.